JDOC vs. GERM
JDOC (Jpmorgan Healthcare Leaders ETF) and GERM (Amplify Treatments, Testing and Advancements ETF) are both Health & Biotech Equities funds. JDOC is actively managed, while GERM is passively managed. Over the past year, JDOC returned 17.29% vs 0.00% for GERM. JDOC charges 0.65%/yr vs 0.68%/yr for GERM.
Performance
JDOC vs. GERM - Performance Comparison
Loading charts...
Returns By Period
JDOC
- 1D
- 1.11%
- 1M
- 2.00%
- YTD
- -0.08%
- 6M
- -0.49%
- 1Y
- 17.29%
- 3Y*
- —
- 5Y*
- —
- 10Y*
- —
GERM
- 1D
- 0.00%
- 1M
- 0.00%
- YTD
- 0.00%
- 6M
- 0.00%
- 1Y
- 0.00%
- 3Y*
- —
- 5Y*
- —
- 10Y*
- —
JDOC vs. GERM - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | |
|---|---|---|---|
JDOC Jpmorgan Healthcare Leaders ETF | -0.08% | 15.36% | -13.95% |
GERM Amplify Treatments, Testing and Advancements ETF | 0.00% | 0.00% | 0.00% |
JDOC vs. GERM - Sectors Allocation Comparison
Sectors
JDOC
GERM
Healthcare
Basic Materials
-
-
Communication Services
-
-
Consumer Cyclical
-
-
Consumer Defensive
-
-
Energy
-
-
Financial Services
-
Industrials
-
-
Real Estate
-
-
Technology
-
-
Utilities
-
-
Healthcare
JDOC
GERM
Basic Materials
JDOC
-
GERM
-
Communication Services
JDOC
-
GERM
-
Consumer Cyclical
JDOC
-
GERM
-
Consumer Defensive
JDOC
-
GERM
-
Energy
JDOC
-
GERM
-
Financial Services
JDOC
-
GERM
Industrials
JDOC
-
GERM
-
Real Estate
JDOC
-
GERM
-
Technology
JDOC
-
GERM
-
Utilities
JDOC
-
GERM
-
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
JDOC vs. GERM — Risk / Return Rank
JDOC
GERM
Risk / return metrics aren't available yet — we need at least 12 months of trading data to calculate them.
JDOC vs. GERM - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Jpmorgan Healthcare Leaders ETF (JDOC) and Amplify Treatments, Testing and Advancements ETF (GERM). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| JDOC | GERM | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | — | — | |
| Sortino ratioReturn per unit of downside risk | — | — | |
| Omega ratioGain probability vs. loss probability | 1.22 | — | — |
| Calmar ratioReturn relative to maximum drawdown | 1.79 | — | — |
| Martin ratioReturn relative to average drawdown | 4.54 | — | — |
Loading charts...
Drawdowns
JDOC vs. GERM - Drawdown Comparison
The maximum JDOC drawdown since its inception was -20.87%, which is greater than GERM's maximum drawdown of 0.00%. Use the drawdown chart below to compare losses from any high point for JDOC and GERM.
Loading charts...
Drawdown Indicators
| JDOC | GERM | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -20.87% | 0.00% | -20.87% |
Max Drawdown (1Y)Largest decline over 1 year | -9.68% | 0.00% | -9.68% |
Current DrawdownCurrent decline from peak | -3.20% | 0.00% | -3.20% |
Average DrawdownAverage peak-to-trough decline | -6.93% | 0.00% | -6.93% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 3.81% | 0.00% | +3.81% |
Volatility
JDOC vs. GERM - Volatility Comparison
Jpmorgan Healthcare Leaders ETF (JDOC) has a higher volatility of 5.26% compared to Amplify Treatments, Testing and Advancements ETF (GERM) at 0.00%. This indicates that JDOC's price experiences larger fluctuations and is considered to be riskier than GERM based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| JDOC | GERM | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 5.26% | 0.00% | +5.26% |
Volatility (6M)Calculated over the trailing 6-month period | 10.56% | 0.00% | +10.56% |
Volatility (1Y)Calculated over the trailing 1-year period | 14.35% | 0.00% | +14.35% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 14.52% | 0.00% | +14.52% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 14.52% | 0.00% | +14.52% |
JDOC vs. GERM - Expense Ratio Comparison
JDOC has a 0.65% expense ratio, which is lower than GERM's 0.68% expense ratio.
Dividends
JDOC vs. GERM - Dividend Comparison
JDOC's dividend yield for the trailing twelve months is around 0.89%, while GERM has not paid dividends to shareholders.
| Position | TTM | 2025 | 2024 | 2023 |
|---|---|---|---|---|
GERM Amplify Treatments, Testing and Advancements ETF | 0.00% | 0.00% | 0.00% | 0.00% |
JDOC Jpmorgan Healthcare Leaders ETF | 0.89% | 0.89% | 5.57% | 0.15% |
Frequently Asked Questions
JDOC has higher volatility (5.26%) compared to GERM (0.00%). In terms of maximum drawdown, JDOC dropped -20.87% vs GERM's 0.00%.
On 1-year performance, JDOC leads with 17.29% vs 0.00% for GERM. On fees, JDOC is cheaper at 0.65% per year. On volatility, GERM has been the lower-risk option at 0.00%. The better choice depends on whether you care most about return, fees, risk, or income.
Over the 1-year period, JDOC has performed better with a 17.29% return vs 0.00%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.
JDOC is cheaper with a 0.65% expense ratio, compared with 0.68% for GERM.
JDOC has the higher dividend yield at 0.89%, compared with 0.00% for GERM.
They also come from different issuers: JPMorgan and Amplify. Their fees differ too: 0.65% for JDOC and 0.68% for GERM.
Find the right allocation for JDOC and GERM
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer